Cross-fund · 5 holders
KNSA
KINIKSA PHARMACEUTICALS INTL
CUSIP G52694109
5
Tracked holders
$233.9M
Aggregate value
5,304,702
Shares
5
Active funds
Funds holding KNSA
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $128.4M | — | +49,802 | +1.6% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $30.9M | 0.04% | −156,179 | −19.6% |
| Millennium | Multi-Strategy | Q1 2026 | $27.2M | 0.01% | −260,865 | −31.6% |
| Citadel | Multi-Strategy | Q1 2026 | $24.1M | — | −254,568 | −33.8% |
| BlackRock | Institutional | Q1 2026 | $23.4M | — | +40,134 | +9.0% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.